Publications by authors named "L Moezi"

Objectives: Exposure to aluminum (Al) has been shown to be strongly associated with the pathogenesis of Alzheimer's disease (AD). Recent evidence indicates that the toxicity of Al nanoparticle (Al-NP) is far greater than Al itself due to its particle size. Epidemiological studies suggest that curcumin lower the prevalence of AD.

View Article and Find Full Text PDF

Background: Edaravone is an anti-stroke medication that may have nitric oxide (NO) modulating properties. This study evaluated the role of NO in the acute and sub-chronic anticonvulsant effects of edaravone in murine models of seizures induced by intraperitoneal (IP) or intravenous (IV) injections of pentylenetetrazole (PTZ) or electroshock (maximal electroshock seizure [MES]).

Methods: 132 male albino mice were randomly divided into 22 groups (n=6) and given IP injections of vehicle or edaravone either acutely or for eight days (sub-chronically).

View Article and Find Full Text PDF

Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disease characterized by brain cholinergic dysfunction. Evidence suggests the impairment of memory retrieval phase in AD. It has been shown that CaMKII-α expressing neurons are selectively reduced in the hippocampus in AD brains.

View Article and Find Full Text PDF
Article Synopsis
  • Agmatine is a polyamine that may function as a neurotransmitter and has the potential to influence memory, specifically passive avoidance memory in mice.
  • A study tested various doses of agmatine over 11 days to assess its effects on memory retention and signaling pathways (CaMKII-α and ERK) in the hippocampus.
  • Results showed a dose-dependent impact where lower doses impaired memory while higher doses improved it, linking these effects to changes in the phosphorylation levels of CaMKII-α and ERK in the brain.
View Article and Find Full Text PDF

Fifteen derivatives of spirooxindole-4H-pyran (A-A) were subjected to evaluate through intravenous infusion of pentylenetetrazole (PTZ)-induced epilepsy mouse models. Four doses of the compounds (20, 40, 60 and 80 mg/kg) were tested in comparison with diazepam as positive control. The resulted revealed that compounds A and A were the most active compounds and indicated significant anticonvulsant activity in the PTZ test.

View Article and Find Full Text PDF